BioClinica, CCBR-SYNARC To Merge
BioClinica and CCBR-SYNARC have signed an agreement to merge their companies
BioClinica and CCBR-SYNARC have signed an agreement to merge their companies, with the combined company offering four highly specialized services to the clinical trials industry. Those services include medical imaging services across multiple therapeutic areas; worldwide network of research centers and sites; consulting services and cardiac safety monitoring services.
Read the full release here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
